Photochemotherapy for localized morphoea: Effect on clinical and molecular markers

Clinical and Experimental Dermatology

Volumn 33, Issue 6, 2008, Pages 698-704

  Usmani, N ^a   Murphy, A ^a   Veale, D ^b   Goulden, V ^a   Goodfield, M ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CD3 ANTIGEN; CD4 ANTIGEN; CLOBETASOL PROPIONATE; CYCLOSPORIN A; MOLECULAR MARKER; PREDNISOLONE; PSORALEN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOCALIZED SCLERODERMA; MALE; MORPHOEA; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PUVA; RODNAN SCORE; SCORING SYSTEM; SEROLOGY; SKIN BIOPSY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIGENS, CD3; ANTIGENS, CD4; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PUVA THERAPY; SCLERODERMA, LOCALIZED; SKIN; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 53349119523     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02890.x     Document Type: Article

References (23)

1. Goodfield M, Jones SK, Veale DJ. The connective tissue diseases. In : Rook's Textbook of Dermatology, 7th edn (Burns T, Breathnach S, Cox N, Griffiths C, eds). Vol. 3. Oxford : Blackwell Publishing, 2004 56.70 56.110.
2. Rowell NR, Scott DG. Immunohistological studies with anti-connective tissue and anti-immunoglobulin antisera of the skin in lupus erythematosus and scleroderma. Br J Dermatol 1975 93 : 431 4.
3. Vincent F, Prokopetz R, Miller RAW. Plasma cell panniculitis: a unique clinical and pathological presentation of linear scleroderma. J Am Acad Dermatol 1989 21 : 357 60.
4. Yamane K, Hironobu I, Masahide K et al. Increased serum levels of soluble vascular cell adhesion molecule 1 and E selectin in patients with localized scleroderma. J Am Acad Dermatol 2000 42 : 64 6.
5. Joly P, Bamberger N, Cricke B et al. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow up study on 17 patients. Arch Dermatol 1994 130 : 663 4.
6. Flanga V, Medsger T. D Penicillamine in the treatment of localized scleroderma. Arch Dermatol 1990 126 : 609 12.
7. Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol 2002 138 : 99 105.
8. Seyger MMB, Van der Hoogen FHJ, de Boo T et al. Low dose methotrexate in the treatment of widespread morphoea. J Am Acad Dermatol 1998 39 : 220 5.
9. Clements P, Seibold JR, Furst DE et al. High dose vs low dose D penicillamine in early diffuse systemic sclerosis: analysis of a 2 year double blind randomized controlled clinical trial. Arthritis Rheum 1999 42 : 1194 203.
10. Tay YK. Topical calcipotriol ointment in the treatment of morphoea. J Dermatolog Treat 2003 14 : 219 21.
11. Kreuter A, Hyun J, Stücker M et al. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006 54 : 440 7.
12. Yin L, Yamauchi R, Tsuji T et al. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to glutathione (GSH) content in skin fibroblasts of systemic sclerosis? J Dermatol 2003 30 : 173 80.
13. Furst DE, Clements PJ, Steen VD et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998 25 : 84 8.
14. Fisher G, Kang S. Phototherapy for scleroderma biological rationale results and promise. Curr Opin Rheumatol 2002 14 : 723 6.
15. Morison WL. Psoralen UVA therapy for linear and generalized morphoea. J Am Acad Dermatol 1997 37 : 657 9.
16. Kerscher M, Meurer M, Sander C et al. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol 1996 132 : 1280 2.
17. Duncan MR, Berman B. Differential regulation of collagen glycosaminoglycans, fibronectin and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1 alphas and beta and tumor necrosis factor alpha and beta. J Invest Dermatol 1989 92 : 699 706.
18. Kahari V, Chen YQ, Su MW et al. Tumour necrosis factor alpha and interferon gamma suppress the activation of human type 1 collagen gene expression by transforming growth factor beta. J Clin Invest 1990 86 : 1489 95.
19. Veale DJ, Maple C, Kirk G et al. Soluble cell adhesion molecules - P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis. Scand J Rheumatol 1998 27 : 296 9.
20. Laing TJ, Richardson BC, Toth MB et al. Ultraviolet light and 8-methoxypsoralen inhibit expression of endothelial adhesion molecules. J Rheumatol 1995 22 : 212 16.
21. Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S. Soluble adhesion molecules (sVCAM-1, sE-selectin) vascular endothelial growth factor (VEGF) and endothelin 1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol 2005 24 : 111 16.
22. Choi JJ, Min DJ, Cho ML et al. Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol 2004 30 : 1529 33.
23. Sato S, Fujimoto M, Kikuchi K et al. Soluble CD4 and CD8 in serum from patients with localized scleroderma. Arch Dermatol Res 1996 288 : 358 62.